Total Ginsenosides from Panax ginseng Improve Exercise Tolerance in Rats with Spleen Qi Deficiency-like Features: Integrated Metabolomics of Serum and Hepatic Mitochondria-enriched Fractions.

IF 6.8 2区 医学 Q1 CHEMISTRY, MEDICINAL
Hui Li, Wantong Zhao, Xiaotong Fu, Meng Ge, Jielin Wang, Wei Wu
{"title":"Total Ginsenosides from Panax ginseng Improve Exercise Tolerance in Rats with Spleen Qi Deficiency-like Features: Integrated Metabolomics of Serum and Hepatic Mitochondria-enriched Fractions.","authors":"Hui Li, Wantong Zhao, Xiaotong Fu, Meng Ge, Jielin Wang, Wei Wu","doi":"10.1016/j.jep.2026.122521","DOIUrl":null,"url":null,"abstract":"<p><strong>Ethnopharmacological relevance: </strong>Panax ginseng C.A.Mey. has traditionally been used to replenish Qi and strengthen the spleen, including for poor appetite and weakness associated with spleen deficiency. Ginsenosides are major constituents, but their metabolic effects under spleen Qi deficiency-like conditions remain to be clarified.</p><p><strong>Aim of the study: </strong>To evaluate whether total ginsenosides (TGS) improve spleen Qi deficiency-like features in rats and characterize systemic and hepatic metabolic changes.</p><p><strong>Materials and methods: </strong>A rat model was established using 50% food restriction combined with repeated weight-loaded swimming, and TGS (75, 150, or 300 mg·kg<sup>-1</sup>) was administered for 21 days. Body weight, grip strength, swimming endurance, biochemical indices, and mitochondrial ultrastructure were evaluated. Untargeted metabolomic analyses of serum and hepatic mitochondria-enriched fractions were performed in the control (CON), model (MOD), and high-dose TGS (TGS-H) groups, and hepatic SIRT1 and PGC-1α protein expression was measured. Lipid accumulation, mitochondrial membrane potential, and SIRT1 and PGC-1α expression were also examined in oleic acid-treated HepG2 cells.</p><p><strong>Results: </strong>TGS, particularly at 300 mg·kg<sup>-1</sup>, attenuated the suppression of body-weight gain and improved grip strength and swimming endurance. These functional improvements were accompanied by increased ATP content and ATPase activities and attenuation of mitochondrial ultrastructural abnormalities. After TGS-H treatment, serum levels of several amino acids increased, and lipid profiles shifted toward the control pattern. In hepatic mitochondria-enriched fractions, accumulation of selected fatty acids decreased, and levels of selected organic acids increased. TGS increased hepatic PGC-1α protein expression at all three doses, whereas SIRT1 expression increased significantly only at the high dose. In oleic acid-treated HepG2 cells, increased expression of both proteins was accompanied by reduced lipid accumulation and partial recovery of mitochondrial membrane potential.</p><p><strong>Conclusions: </strong>In rats with spleen Qi deficiency-like features induced by limited nutritional supply and repeated physical exertion, TGS attenuated the suppression of body-weight gain and improved exercise tolerance, accompanied by changes in energy-related indices. These findings provide experimental support for the traditional use of ginseng to replenish Qi and strengthen the spleen in relation to symptoms of weakness.</p>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":" ","pages":"122521"},"PeriodicalIF":6.8000,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of ethnopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jep.2026.122521","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Ethnopharmacological relevance: Panax ginseng C.A.Mey. has traditionally been used to replenish Qi and strengthen the spleen, including for poor appetite and weakness associated with spleen deficiency. Ginsenosides are major constituents, but their metabolic effects under spleen Qi deficiency-like conditions remain to be clarified.

Aim of the study: To evaluate whether total ginsenosides (TGS) improve spleen Qi deficiency-like features in rats and characterize systemic and hepatic metabolic changes.

Materials and methods: A rat model was established using 50% food restriction combined with repeated weight-loaded swimming, and TGS (75, 150, or 300 mg·kg-1) was administered for 21 days. Body weight, grip strength, swimming endurance, biochemical indices, and mitochondrial ultrastructure were evaluated. Untargeted metabolomic analyses of serum and hepatic mitochondria-enriched fractions were performed in the control (CON), model (MOD), and high-dose TGS (TGS-H) groups, and hepatic SIRT1 and PGC-1α protein expression was measured. Lipid accumulation, mitochondrial membrane potential, and SIRT1 and PGC-1α expression were also examined in oleic acid-treated HepG2 cells.

Results: TGS, particularly at 300 mg·kg-1, attenuated the suppression of body-weight gain and improved grip strength and swimming endurance. These functional improvements were accompanied by increased ATP content and ATPase activities and attenuation of mitochondrial ultrastructural abnormalities. After TGS-H treatment, serum levels of several amino acids increased, and lipid profiles shifted toward the control pattern. In hepatic mitochondria-enriched fractions, accumulation of selected fatty acids decreased, and levels of selected organic acids increased. TGS increased hepatic PGC-1α protein expression at all three doses, whereas SIRT1 expression increased significantly only at the high dose. In oleic acid-treated HepG2 cells, increased expression of both proteins was accompanied by reduced lipid accumulation and partial recovery of mitochondrial membrane potential.

Conclusions: In rats with spleen Qi deficiency-like features induced by limited nutritional supply and repeated physical exertion, TGS attenuated the suppression of body-weight gain and improved exercise tolerance, accompanied by changes in energy-related indices. These findings provide experimental support for the traditional use of ginseng to replenish Qi and strengthen the spleen in relation to symptoms of weakness.

人参总皂苷改善脾虚样大鼠运动耐量:血清和肝脏线粒体富集组分的综合代谢组学研究
民族药理学相关性:人参。传统上被用来补气健脾,包括治疗食欲不振和脾虚虚弱。人参皂苷是主要成分,但其在脾虚条件下的代谢作用仍有待阐明。研究目的:评价总人参皂苷(TGS)是否能改善大鼠脾虚样特征,并表征全身和肝脏代谢变化。材料与方法:采用50%限食联合反复负重游泳建立大鼠模型,给予TGS(75、150、300 mg·kg-1) 21 d。测定体重、握力、游泳耐力、生化指标和线粒体超微结构。对照组(CON)、模型组(MOD)和高剂量TGS组(TGS- h)对血清和肝脏线粒体富集部位进行非靶向代谢组学分析,并测定肝脏SIRT1和PGC-1α蛋白表达。在油酸处理的HepG2细胞中,还检测了脂质积累、线粒体膜电位、SIRT1和PGC-1α的表达。结果:TGS,特别是300 mg·kg-1时,减轻了体重增加的抑制,提高了握力和游泳耐力。这些功能的改善伴随着ATP含量和ATP酶活性的增加以及线粒体超微结构异常的减弱。经TGS-H治疗后,血清中几种氨基酸水平升高,脂质谱向对照模式转移。在肝脏线粒体富集组分中,选定脂肪酸的积累减少,选定有机酸的水平增加。TGS在三种剂量下均增加肝脏PGC-1α蛋白表达,而SIRT1表达仅在高剂量下显著增加。在油酸处理的HepG2细胞中,这两种蛋白的表达增加伴随着脂质积累的减少和线粒体膜电位的部分恢复。结论:在营养供应有限、反复体力消耗所致脾虚样大鼠中,TGS可减弱对体重增加的抑制作用,提高运动耐量,并伴有能量相关指标的改变。这些发现为传统使用人参补气健脾治疗虚弱症状提供了实验支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of ethnopharmacology
Journal of ethnopharmacology 医学-全科医学与补充医学
CiteScore
10.30
自引率
5.60%
发文量
967
审稿时长
77 days
期刊介绍: The Journal of Ethnopharmacology is dedicated to the exchange of information and understandings about people''s use of plants, fungi, animals, microorganisms and minerals and their biological and pharmacological effects based on the principles established through international conventions. Early people confronted with illness and disease, discovered a wealth of useful therapeutic agents in the plant and animal kingdoms. The empirical knowledge of these medicinal substances and their toxic potential was passed on by oral tradition and sometimes recorded in herbals and other texts on materia medica. Many valuable drugs of today (e.g., atropine, ephedrine, tubocurarine, digoxin, reserpine) came into use through the study of indigenous remedies. Chemists continue to use plant-derived drugs (e.g., morphine, taxol, physostigmine, quinidine, emetine) as prototypes in their attempts to develop more effective and less toxic medicinals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书